SELLAS Life Sciences Group, Inc.
Status: Publicly traded
Direct answer
SELLAS Life Sciences Group, Inc. is publicly traded on NASDAQ under the ticker SLS.
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It...
Can you invest in SELLAS Life Sciences Group, Inc.?
Yes. SELLAS Life Sciences Group, Inc. trades publicly on NASDAQ as SLS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for SELLAS Life Sciences Group, Inc.
Detailed equity research is provided by MarketSnap.